Compare Opendoor Technologies Inc (OPEN) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Opendoor Technologies Inc vs Revolution Medicines Inc. Common Stock — how do they compare? Opendoor Technologies Inc trades at $2.23 (market cap $2.22B), while Revolution Medicines Inc. Common Stock trades at $191 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 18.2× Opendoor Technologies Inc's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Opendoor Technologies Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Opendoor Technologies Inc for 33 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| OPEN | RVMD | |
|---|---|---|
Market Cap | $2.22B | $40.32B |
Volume | 28,705,892 | 4,855,734 |
Sector | Real Estate | Health |
52-Week High | $9.37 | $221.15 |
52-Week Low | $2.27 | $47.50 |
Typical Hold Time | 33 Days | 0 Days |
Enterprise Value | $3.29B | $37.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Opendoor Technologies (OPEN) trades at $2.215, down 2.42% on the day, reflecting ongoing challenges in the iBuying sector. The stock shows bearish technical signals with negative moving averages and oscillators, while fundamentals reveal significant losses with a -46.74% net income margin and -$1.3B net loss in 2025. Recent news highlights mortgage expansion efforts and housing market sensitivity to interest rate fluctuations, with the company aiming for adjusted net income breakeven at a $9B revenue run rate.
Despite trading near analyst consensus price target of $4.92 (122% upside), OPEN faces substantial execution risks amid persistent losses and high debt levels. The bullish case relies on successful mortgage expansion and housing market recovery, but current financial metrics and technical indicators suggest continued volatility. Investors should weigh the significant discount to analyst targets against the company's challenging path to profitability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Opendoor Technologies Inc
Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.
Read more on OPEN →About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →
